Moreover, activating mutations in the Ras or phosphoinositide 3-kinase (PI3K) pathway do not overcome the requirement of a functional p130Cas/FAK signalling complex for the survival and growth of human breast cancer cells [17]. The gene discussed is BCAR1; the disease is breast carcinoma.